Display options
Share it on

Ann Transl Med. 2015 Dec;3(22):364. doi: 10.3978/j.issn.2305-5839.2015.12.10.

The evolving evidence for the efficacy and safety of charged particle therapy for hepatocellular carcinoma-a commentary.

Annals of translational medicine

Jillian Gunther, Sunil Krishnan

Affiliations

  1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

PMID: 26807419 PMCID: PMC4701530 DOI: 10.3978/j.issn.2305-5839.2015.12.10

[No abstract available.]

References

  1. Lancet Oncol. 2015 Jun;16(6):630-7 - PubMed
  2. Pract Radiat Oncol. 2015 Jul-Aug;5(4):209-18 - PubMed
  3. Radiother Oncol. 2014 Apr;111(1):1-10 - PubMed
  4. Semin Radiat Oncol. 2011 Oct;21(4):278-86 - PubMed
  5. Liver Transpl. 2005 Sep;11(9):1086-92 - PubMed
  6. Acta Oncol. 2015 Nov;54(10):1827-32 - PubMed
  7. World J Hepatol. 2015 Jun 18;7(11):1553-61 - PubMed
  8. Radiother Oncol. 2016 Feb;118(2):420 - PubMed
  9. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):661-3 - PubMed
  10. Radiother Oncol. 2015 Mar;114(3):289-95 - PubMed

Publication Types